US Patent Office Names Illumina 'Senior Party' in IP Interference Case With Affy | GenomeWeb
NEW YORK (GenomeWeb News) — The US Patent and Trademark Office said that a patent interference exists between an Illumina patent application and Affymetrix’ inversion probe genotyping technology, and has named Illumina the ‘senior party’ in the case, Illumina said today.
The decision pertains to a lawsuit filed by Affymetrix against Illumina in July 2004 that claims Illumina infringes six patented DNA microarray and related technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.